✦ LIBER ✦

Revisiting the cost-effectiveness of omalizumab

✍ Scribed by J. D. Campbell; D. E. Spackman; S. D. Sullivan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of cost-effectiveness of omalizumab

✍ Miller, Thomas P.; Reeves, Mathew J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Has the cost-effectiveness of Xolair (om

✍ ASCHE, C; BRIXNER, D; ODERDA, G 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Cost-effectiveness of omalizumab in pati

✍ R. Brown; F. Turk; P. Dale; J. Bousquet 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

An evaluation of the cost-effectiveness

✍ S. D. Sullivan; F. Turk 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB

Revisiting the decision rule of cost–eff

✍ Pedram Sendi; Maiwenn J. Al 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Cost-effectiveness of omalizumab in adul

✍ Wu, Ann C.; Paltiel, A. David; Kuntz, Karen M.; Weiss, Scott T.; Fuhlbrigge, Ann 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 193 KB